Small Peptide Modulation of Fibroblast Growth Factor Receptor 3-Dependent Postnatal Lymphangiogenesis-Reference-Cited by-同舟云学术

Small Peptide Modulation of Fibroblast Growth Factor Receptor 3-Dependent Postnatal Lymphangiogenesis

Published:2019-02 Issue:1 Volume:17 Page:19-29
ISSN:1539-6851
Container-title:Lymphatic Research and Biology
language:en
Short-container-title:Lymphatic Research and Biology

Author:

Perrault David P.¹,Lee Gene K.¹,Park Sun Young¹,Lee Sunju²,Choi Dongwon²,Jung Eunson²,Seong Young Jin²,Park Eun Kyung²,Sung Cynthia¹,Yu Roy¹,Bouz Antoun¹,Pourmoussa Austin¹,Kim Soo Jung¹,Hong Young-Kwon²,Wong Alex K.¹

Affiliation:

1. Division of Plastic and Reconstructive Surgery, Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California.

2. Department of Biochemistry and Molecular Biology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.

Publisher

Mary Ann Liebert Inc

Subject

Cardiology and Cardiovascular Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/lrb.2018.0035

Reference48 articles.

1. Structural basis for fibroblast growth factor receptor activation

2. The FGF family: biology, pathophysiology and therapy

3. FGF-dependent metabolic control of vascular development

4. A novel FGFR3-binding peptide inhibits FGFR3 signaling and reverses the lethal phenotype of mice mimicking human thanatophoric dysplasia

5. Achondroplasia: Development, pathogenesis, and therapy

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent trends in the design and delivery strategies of ruthenium complexes for breast cancer therapy;Dalton Transactions;2024

2. Dual FGFR-targeting and pH-activatable ruthenium–peptide conjugates for targeted therapy of breast cancer;Dalton Transactions;2024

3. Molecular and metabolic orchestration of the lymphatic vasculature in physiology and pathology;Nature Communications;2023-12-16

4. The Future of Lymphedema: Potential Therapeutic Targets for Treatment;Current Breast Cancer Reports;2023-06-01

5. New developments in the biology of fibroblast growth factors;WIREs Mechanisms of Disease;2022-02-09